Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Karen Laliberte's publication output changed over time?
ScholarIQpublication output · 2010–2023
Output grew0% over the shown period — from 1 works in 2010 to 1 in 2023.
1
1
1
1
1
1
1
1
1
1
2010201120122014201620172018202020212023
What are the most-cited papers on Karen Laliberte?
ScholarIQmost cited works
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Orlando M. Gutiérrez, James L. Januzzi, Tamara Isakova, Karen Laliberte, Kelsey Smith, Gina Collerone, Ammar Sarwar, Udo Hoffmann, Erin Coglianese, Robert H. Christenson, Thomas J. Wang, Christopher R. deFilippi, Myles Wolf
Circulation. 2009827 CitationsOPEN ACCESS
Contaminated Cocaine and Antineutrophil Cytoplasmic Antibody-Associated Disease
Martina M. McGrath, Tamara Isakova, Helmut G. Rennke, Ann M. Mottola, Karen Laliberte, John L. Niles
Clinical Journal of the American Society of Nephrology. 2011190 Citations
Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Eugene P. Rhee, Karen Laliberte, John L. Niles
Clinical Journal of the American Society of Nephrology. 2010120 CitationsOPEN ACCESS
Long-Term Maintenance Therapy Using Rituximab-Induced Continuous B-Cell Depletion in Patients with ANCA Vasculitis
William F. Pendergraft, Frank B. Cortazar, Julia Wenger, Andrew P. Murphy, Eugene P. Rhee, Karen Laliberte, John L. Niles
Clinical Journal of the American Society of Nephrology. 2014109 CitationsOPEN ACCESS
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
Frank B. Cortazar, Saif A. Muhsin, William F. Pendergraft, Zachary S. Wallace, Colleen Dunbar, Karen Laliberte, John L. Niles
Kidney International Reports. 2017103 CitationsOPEN ACCESS
Related on ScholarIQ
Massachusetts General Hospital
Institution
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Paper
Contaminated Cocaine and Antineutrophil Cytoplasmic Antibody-Associated Disease
Paper
Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Paper
Long-Term Maintenance Therapy Using Rituximab-Induced Continuous B-Cell Depletion in Patients with ANCA Vasculitis
Paper
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
Paper